UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+0.05%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$3.52B
AUM Growth
+$53.7M
(+1.5%)
Cap. Flow
-$42.8M
Cap. Flow
% of AUM
-1.22%
Top 10 Holdings %
Top 10 Hldgs %
49.92%
Holding
595
New
104
Increased
143
Reduced
92
Closed
93
Top Buys
| 1 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
+$150M |
| 2 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$129M |
| 3 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$127M |
| 4 |
MRO
Marathon Oil Corporation
MRO
|
+$127M |
| 5 |
CHX
ChampionX
CHX
|
+$95.7M |
Top Sells
Sector Composition
| 1 | Energy | 26.72% |
| 2 | Technology | 21.14% |
| 3 | Healthcare | 14.79% |
| 4 | Industrials | 8.25% |
| 5 | Materials | 6.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Gilead Sciences
GILD
$144B
| $686K | 0.02% |
+10,000
| New | +$686K |
|
327
Aura Biosciences
AURA
$402M
| $685K | 0.02% |
90,619
+23,294
| +35% | +$176K |
|
328
HilleVax
HLVX
$105M
| $679K | 0.02% |
46,970
+1,294
| +3% | +$18.7K |
|
329
X4 Pharmaceuticals
XFOR
$76.1M
| $673K | 0.02% |
38,684
-5,833
| -13% | -$101K |
|
330
Micron Technology
MU
$147B
| $658K | 0.02% |
5,000
-20,000
| -80% | -$2.63M |
|
|
THRD
331
DELISTED
Third Harmonic Bio
THRD
| $640K | 0.02% |
49,251
+848
| +2% | +$11K |
|
332
Ardelyx
ARDX
$1.59B
| $627K | 0.02% |
84,593
-27,296
| -24% | -$202K |
|
333
Inspire Medical Systems
INSP
$2.47B
| $614K | 0.02% |
4,585
-3,500
| -43% | -$468K |
|
334
Soleno Therapeutics
SLNO
$3.84B
| $612K | 0.02% |
+15,000
| New | +$612K |
|
335
Acrivon Therapeutics
ACRV
$56.3M
| $610K | 0.02% |
105,249
-21,700
| -17% | -$126K |
|
336
Disc Medicine
IRON
$2.15B
| $600K | 0.02% |
13,319
+10,000
| +301% | +$451K |
|
337
Context Therapeutics
CNTX
$73.7M
| $589K | 0.02% |
293,758
-2,917
| -1% | -$5.85K |
|
338
PayPal
PYPL
$65.3B
| $580K | 0.02% |
10,000
-7,500
| -43% | -$435K |
|
|
BHAC
339
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
| $577K | 0.02% |
54,209
| – | – |
|
340
Skillsoft
SKIL
$129M
| $577K | 0.02% |
41,692
| – | – |
|
341
Boston Scientific
BSX
$160B
| $547K | 0.02% |
7,100
-7,700
| -52% | -$593K |
|
342
Merus
MRUS
$5.08B
| $533K | 0.02% |
9,000
-22,642
| -72% | -$1.34M |
|
|
ITOS
343
DELISTED
iTeos Therapeutics
ITOS
| $524K | 0.01% |
+35,323
| New | +$524K |
|
344
EPR Properties
EPR
$4.05B
| $512K | 0.01% |
12,200
+5,600
| +85% | +$235K |
|
345
Lucid Motors
LCID
$5.67B
| $496K | 0.01% |
+19,010
| New | +$496K |
|
346
Align Technology
ALGN
$9.92B
| $491K | 0.01% |
+2,034
| New | +$491K |
|
347
Vaxcyte
PCVX
$4.21B
| $476K | 0.01% |
6,307
+300
| +5% | +$22.7K |
|
348
NNN REIT
NNN
$8.12B
| $470K | 0.01% |
11,038
+338
| +3% | +$14.4K |
|
349
Icon
ICLR
$13.8B
| $468K | 0.01% |
1,492
+520
| +53% | +$163K |
|
350
Cooper Companies
COO
$13.7B
| $462K | 0.01% |
5,289
+100
| +2% | +$8.73K |
|